Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kastrinou-Lampou V"'
Autor:
Kastrinou-Lampou V; Pharmacokinetic Sciences, BioMedical Research, Novartis, Basel, Switzerland.; Preclinical Safety, BioMedical Research, Novartis, Basel, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Rodríguez-Pérez R; Pharmacokinetic Sciences, BioMedical Research, Novartis, Basel, Switzerland., Poller B; Pharmacokinetic Sciences, BioMedical Research, Novartis, Basel, Switzerland., Huth F; Pharmacokinetic Sciences, BioMedical Research, Novartis, Basel, Switzerland., Schadt HS; Preclinical Safety, BioMedical Research, Novartis, Basel, Switzerland., Kullak-Ublick GA; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Mechanistic Safety, CMO and Patient Safety, Global Drug Development, Novartis, Basel, Switzerland., Arand M; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Camenisch G; Pharmacokinetic Sciences, BioMedical Research, Novartis, Basel, Switzerland. gian.camenisch@novartis.com.
Publikováno v:
Archives of toxicology [Arch Toxicol] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.
Autor:
Kastrinou-Lampou V; Pharmacokinetic Sciences, BioMedical Research, Novartis, Basel, Switzerland.; Preclinical Safety, BioMedical Research, Novartis, Basel, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Rodríguez-Pérez R; Pharmacokinetic Sciences, BioMedical Research, Novartis, Basel, Switzerland., Poller B; Pharmacokinetic Sciences, BioMedical Research, Novartis, Basel, Switzerland., Huth F; Pharmacokinetic Sciences, BioMedical Research, Novartis, Basel, Switzerland., Gáborik Z; SOLVO Biotechnology, Charles River Laboratories Hungary, 1117, Budapest, Hungary., Mártonné-Tóth B; SOLVO Biotechnology, Charles River Laboratories Hungary, 1117, Budapest, Hungary., Temesszentandrási-Ambrus C; SOLVO Biotechnology, Charles River Laboratories Hungary, 1117, Budapest, Hungary., Schadt HS; Preclinical Safety, BioMedical Research, Novartis, Basel, Switzerland., Kullak-Ublick GA; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Mechanistic Safety, CMO & Patient Safety, Global Drug Development, Novartis, Basel, Switzerland., Arand M; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Camenisch G; Pharmacokinetic Sciences, BioMedical Research, Novartis, Basel, Switzerland. gian.camenisch@novartis.com.
Publikováno v:
Archives of toxicology [Arch Toxicol] 2024 Oct; Vol. 98 (10), pp. 3409-3424. Date of Electronic Publication: 2024 Jul 18.
Autor:
Kastrinou Lampou V; Department of Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Basel, Switzerland; Department of Preclinical Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Poller B; Department of Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Basel, Switzerland., Huth F; Department of Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Basel, Switzerland., Fischer A; Department of Preclinical Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland., Kullak-Ublick GA; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Mechanistic Safety, CMO & Patient Safety, Global Drug Development, Novartis, Basel, Switzerland., Arand M; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Schadt HS; Department of Preclinical Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland., Camenisch G; Department of Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Basel, Switzerland. Electronic address: gian.camenisch@novartis.com.
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA [Toxicol In Vitro] 2023 Mar; Vol. 87, pp. 105533. Date of Electronic Publication: 2022 Dec 05.
Autor:
Hurrell T; Ingelman-Sundberg Group, Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, 171 65 Stockholm, Sweden., Kastrinou-Lampou V; Ingelman-Sundberg Group, Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, 171 65 Stockholm, Sweden., Fardellas A; Ingelman-Sundberg Group, Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, 171 65 Stockholm, Sweden., Hendriks DFG; Ingelman-Sundberg Group, Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, 171 65 Stockholm, Sweden., Nordling Å; Ingelman-Sundberg Group, Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, 171 65 Stockholm, Sweden., Johansson I; Ingelman-Sundberg Group, Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, 171 65 Stockholm, Sweden., Baze A; KaLy-Cell, 67115 Plobsheim, France., Parmentier C; KaLy-Cell, 67115 Plobsheim, France., Richert L; KaLy-Cell, 67115 Plobsheim, France., Ingelman-Sundberg M; Ingelman-Sundberg Group, Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, 171 65 Stockholm, Sweden.
Publikováno v:
Cells [Cells] 2020 Apr 14; Vol. 9 (4). Date of Electronic Publication: 2020 Apr 14.